AgNovos Receives Breakthrough Device Designation for Spine Device

AgNovos Healthcare AGN1 LOEP SV Kit

AgNovos Healthcare was granted Breakthrough Device Designation by FDA for the AGN1 Local Osteo-enhancement Procedure Small Volume (LOEP SV) Kit. If cleared, the kit would represent a breakthrough treatment for stable vertebral compression fractures.

AGN1 LOEP SV contains a proprietary calcium-based resorbable tri-phasic implant material...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us